New Delhi, March 22 (IANS) Eleven vaccines against Tuberculosis (TB) are currently in phase II and III stages of development, which may be key to curbing the rising disease burden globally, said a report on Friday, ahead of World TB Day on March 24.
According to the World Health Organization (WHO), TB affects an estimated 1.8 billion people worldwide and is also one of the leading causes of death globally.
The report from GlobalData, a data and analytics company, revealed that the 11 vaccines against TB include “the Gamaleya Federal Research Center of Epidemiology and Microbiology mTBvac and the University of Zaragoza’s MTBVAC, both of which are currently in Phase III development and have demonstrated positive safety and efficacy results in clinical trials”.
“Progress in this area has the potential to save countless lives as well as reduce the health and socio-economic burden associated with this disease,” said Anaelle Tannen, Infectious Disease Analyst at GlobalData, in a statement.
Chronic cough and bloody mucus are the major symptoms of TB, however, some are also present without these symptoms. Early detection is of utmost importance, which can help start a six-month course of antibiotics coupled with proper nutrition to help control the infection.
“Prevention and early diagnosis are key to stopping the ongoing spread of the disease. The Bacillus Calmette-Guerin (BCG) vaccine is currently the only prophylactic on the market. It is given to babies in countries where TB is common. In areas where TB is less common, it is only given to those at high risk, including those that are more likely to be exposed to the bacterium,” Tannen said.
The 100-year-old BCG vaccine is up to 80 per cent effective at preventing TB infection for up to 15 years in young children. However, its protection wanes against pulmonary TB in adolescents and adults. Thus, there is an urgent need for updated and improved prophylactic vaccines.
“Governments worldwide must come together to combat this deadly disease. Increased investment, improved awareness, and adoption of WHO recommendations are essential to reduce the burden of TB over time,” Tannen said.
–IANS
rvt/svn
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
